Glass Industry News

Bormioli Pharma acquires German company ISO GmbH

, Bormioli Pharma

Today, Bormioli Pharma announces the acquisition of ISO Arzneiverpackungen Gmbh, a German company specialized in the production of pharmaceutical packaging and, in particular, of tubular glass vials (Type I, II, III) designed for the injectable drugs, vaccines and chromatography markets.

With an annual production of over 100 million vials, ISO’s headquarters and production plant are located in Bad Königshofen, Northern Bavaria and the company employs over 100 people.

The acquisition – through its German subsidiary Remy & Geiser – will allow Bormioli Pharma to broaden its range of packaging for parenteral drugs even further. It follows recent investments in the Bergantino (Rovigo) and San Vito al Tagliamento (Pordenone) plants and the acquisition of GCL Pharma in Vasto (Chieti), in April, which allowed for the addition of a wide range of rubber and aluminium closures for vials for injectable drugs to be added to the product portfolio.

From an industrial perspective, Bormioli Pharma will double its production capacity of tubular borosilicate glass vials, placing it among the top 10 producers in Europe for the number of containers produced annually, and significantly increase its share of the Central and Northern European market where it had already strengthened its presence last year as a result of the acquisition of Remy & Geiser.

“Thanks to this acquisition, we continue with our expansion plan, further growing our industrial presence in a market that represents important development opportunities” commented Andrea Lodetti, CEO of Bormioli Pharma – “Our commitment does not end here, and over the coming months we will invest even further, particularly in the areas of product innovation and industrial automation and digitalization in order to make our pharmaceutical and nutraceutical packaging range even broader, more diversified and able to support the needs of even the most demanding players in the market.”

“I am proud that ISO has become part of a solid, international group like Bormioli Pharma” commented Marc Jeanrichard, former ISO shareholder and driving force behind the company through a period of growth and success in a complex and competitive market. “Thanks to this acquisition, ISO will benefit from further development potential and broaden its future horizons. I firmly believe in this project and I am honoured to leave a legacy of technical skills and professionalism that will help both companies achieve new goals.”

The acquisition of ISO represents a further step in Bormioli Pharma’s growth and expansion plan since it became part of the Triton investment fund portfolio at the end of 2017. Over the last 3 years, the company has invested considerable resources into industrial enhancement and commercial growth projects, both organically and through acquisitions.

The Bergantino (Rovigo) and San Vito al Tagliamento (Pordenone) production plants have recently undergone renovation and expansion works with the refurbishment of the main furnaces and the installation of additional production lines, while at the Rivanazzano (Pavia) plant a significant industrial digitalization and production line automation project was implemented.

The acquisition announced today follows those already completed previously, with the German company Remy & Geiser Gmbh at the end of 2019 and the Italian company GCL Pharma in April 2020, whose headquarters and plant are located in Vasto (Chieti).

, © Bormioli Pharma

News material on the Site is copyright and belongs to the Company or to its third party news provider, and all rights are reserved. Any User who accesses such material may do so only for its own personal use, and the use of such material is at the sole risk of the User. Redistribution or other commercial exploitation of such news material is expressly prohibited. Where such news material is provided by a third party, each User agrees to observe and be bound by the specific terms of use applying to such news material. We do not represent or endorse the accuracy or reliability of any of the info contained in any news or external websites referred to in the news.

Should the content or the design of these sites violate third parties rights or legal prescriptions, we kindly ask you to send us a respective message without invoice or cost. We guarantee that passages where the claim is considered as justified will be removed immediately, without any necessity to involve any lawyer into this issue. We will reject any claim caused by submission of a honorary note in this regard without any prior contact and confirmation of the issueby us and we reserve the right ssue counter claim ourselves because of violation of aforesaid conditions.



Info Grid

Glass studies

Updated worldwide glass study 2024

plants.glassglobal.com

Updated hollow glass study 2024

Request more information

Updated float glass study 2024

Request more information

Further glass market studies

Request more information

Company Profile



Updated worldwide glass market study 2024 available now for flat, container glass and tableware

We have updated our international studies on flat glass, container glass and tableware for 2024.

This unique software provides a global overview about glass producers and technical details. Easy to use and clear tables summarize information and data about glass makers such as: Glass types: flat glass, container glass, tableware, production capacities in regions and countries, number of furnaces, furnace types, year of construction, glass types and sub-types, products, project information, special news and downloads.

Further databases supplying demoscopic data and import and export data complete the market survey. Based on these data, prepare individual country profiles with information about local production capacities, local market sizes and expected demand in the future.

Request your offer via plants.glassglobal.com.

Updated container glass study 2024

X

Updated float glass study 2024

X

Further glass studies and reports 2024

X